ESR1 and breast neoplasm: No PET-derived variables were associated with recurrence-free survival.<h4>Conclusion</h4>A considerable proportion of estrogen receptor-positive breast tumours showed low SUV max , indicating potential suboptimal staging on [ 18 F]FDG PET.